
one day soon i'll have journal access again and i'll see if I can dig up some raw data. would like to see exactly how many there were with ms, how many with gout, and how many with both.
Sorry to have to go back to an old post, but the comment that Zinc can worsen MS drew me back slightly. can anyone elaborate on this?Jimpsull wrote:The topic of this thread is related to the reason (uric acid) why MS and gout are nearly mutually exclusive, and also why the exception to the rule is posting in this thread. The research on inosine for abatement of MS symptoms indicates that kidney stones and gout are potential risks of raising serum uric acid levels, which is what inosine does.
The protocol for people taking isosine in phase II trials includes at least 8 glasses of water a day. That has me taking a lot of trips to the bathroom. ) :
Regarding the person who saw no effect from inosine, have you had your serum zinc levels measured? I am NOT a fan of blindly supplementing with zinc - it can exacerbate MS. However if you are zinc deficient the body won't be able to convert the inosine to uric acid (so it will be ineffective).
Careful not to oversimplify opinions that disagree with yours.jimmylegs wrote:i believe that would relate to zinc being known to support a healthy immune system, which can be shortened to 'immune booster', which then can be (mis)interpreted as a bad thing, because the immune system is already misbehaving, so why 'boost' bad behaviour.
my 2c, language can be troublesome. don't ignore deficits in essential nutrients when immune system dysfunction is known to be one of the consequences.
There are opposing views out there to just about everything.Abstract
Previous studies have shown that zinc levels in erythrocytes are significantly elevated in patients with multiple sclerosis (MS). To examine the correlation between erythrocyte Zn levels and disease activity, we measured erythrocyte Zn levels longitudinally. Levels were dramatically decreased during a clinically documented exacerbation of MS. To determine the localization of increased Zn levels in MS erythrocytes, we employed standard techniques for the isolation of nonhemoglobin erythrocyte membrane ghosts. Patients with MS had three times more Zn in ghost material than did controls [I have no idea what they mean by "ghost material"...]. Chloroform–methanol extraction in erythrocyte ghosts followed by determination of Zn levels indicated that most of the membrane-bound Zn was associated with the lipid-soluble fraction. Non-lipid-associated Zn and total membrane protein concentration were similar in MS and control samples. Results suggest that mechanisms which govern cellular availability, compartmentalization of Zn, or the binding of Zn to cell surface membranes may be altered in patients with MS, and that these mechanisms vary with disease activity.
Ghosts are red blood cells that have been lysed. All of the hemoglobin has been lost and they look like clear round membranous sacks.CureOrBust wrote:[I have no idea what they mean by "ghost material"...]